Enhancing Access to COVID-19 Breakthrough Therapy with Virus Neutralizing Antibodies: Strategies for Equitable Care

CME: 1.0

May 21, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

The primary intended audience for this education includes practicing US HCPs who are involved in the care and treatment of patients with COVID-19 in an outpatient setting, including physicians, NPs, PAs, registered nurses, and pharmacists.

Statement of Need/Program Overview


Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Recognize SARS-CoV-2-infected patients with mild to moderate COVID-19 who could benefit from NaBs treatments
  • Counsel and orient SARS-CoV-2-infected patients displaying mild to moderate symptoms to appropriate treatment or care based on their risk for hospitalization.

Post a comment to this article